Article Versions Notes

Kerskes CHM, van den Eijnde CJME, Aarnoudse A-JLHJ, Grouls RJE, Deiman BALM, Deenen MJ. The Effect of Genotyping on the Number of Pharmacotherapeutic Gene–Drug Interventions in Chronic Kidney Disease Patients. Pharmacy. 2023; 11(2):69. https://doi.org/10.3390/pharmacy11020069

Kerskes, Catharina H. M., Carien J. M. E. van den Eijnde, Albert-Jan L. H. J. Aarnoudse, René J. E. Grouls, Birgit A. L. M. Deiman, and Maarten J. Deenen. 2023. "The Effect of Genotyping on the Number of Pharmacotherapeutic Gene–Drug Interventions in Chronic Kidney Disease Patients" Pharmacy 11, no. 2: 69. https://doi.org/10.3390/pharmacy11020069

Kerskes, C. H. M., van den Eijnde, C. J. M. E., Aarnoudse, A. -J. L. H. J., Grouls, R. J. E., Deiman, B. A. L. M., & Deenen, M. J. (2023). The Effect of Genotyping on the Number of Pharmacotherapeutic Gene–Drug Interventions in Chronic Kidney Disease Patients. Pharmacy, 11(2), 69. https://doi.org/10.3390/pharmacy11020069